Article By:
PR Newswire
Tuesday, March 9, 2021 4:00 PM EDT
The Company signed an agreement with The Sheba Fund for Health Services and Research at Chaim Sheba Medical Center, to examine the potential role of SCI-210 on status epilepticus.
Therapix - Out With The Old, In With The New
@[Kfir Silverman](user:133973), so not only do you completely fail to make your case against $TRPX, but you don't even bother responding to any comments or questions. Not impressed.
Therapix - Out With The Old, In With The New
Would have been nice had the author responded. I would have liked to have learned more about this. $TRPX
Therapix - Out With The Old, In With The New
I bought $TRPX at $8.60 back in March 2017 after reading a very encouraging article by @[Stone Fox Capital](user:15392). Now it's nearly worthless. One of my worst buys ever. Not Sure what Stone Fox would say about it now.
I for one would like someone to be accountable, and want to know exactly what went wrong. Unfortunately this article does not shed much light onto the situation. If management is to blame, they should be ousted. But I'm still not clear on where the blame should be placed.
Therapix - Out With The Old, In With The New
I agree that $TRPX's performance has been dismal and I clearly remember back when the stock was over $7. I think the management team must be inept to have had the company lose so much of it's value.